PAVmed Inc. to Hold Business Update Conference Call on April 11, 2018
04 Abril 2018 - 8:30AM
Business Wire
PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a
highly differentiated, multiproduct medical device company, today
announced that the Company will host a conference call on
Wednesday, April 11, 2018 at 4:30 p.m. Eastern time. During the
call, Lishan Aklog, M.D., Chairman and Chief Executive Officer of
the Company, will provide a business update including an overview
of the Company’s near-term milestones and growth strategy. In
addition, Dennis McGrath, the Company’s Chief Financial Officer,
will discuss fourth quarter 2017 financial results.
To access the conference call, U.S.-based listeners should dial
(888) 803-5993 and international listeners should dial (706)
634-5454. All listeners should provide the operator with the
following passcode: 8357049. Individuals interested in listening to
the live conference call via the internet may do so by visiting the
Company’s website at www.pavmed.com.
Following the conclusion of the conference call, a replay will
be available through April 16, 2018 and can be accessed by dialing
(855) 859-2056 from within the U.S. or (404) 537-3406 from outside
the U.S. To access the replay, all listeners should provide the
following passcode: 8357049. The webcast will be available for a
period of time on the Company’s website at www.pavmed.com.
About PAVmed
PAVmed Inc. is a highly differentiated, multiproduct medical
device company employing a unique business model designed to
advance innovative products to commercialization much more rapidly
and with significantly less capital than the typical medical device
company. This proprietary model enables PAVmed to pursue an
expanding pipeline strategy with a view to enhancing and
accelerating value creation. PAVmed’s diversified pipeline of
products address unmet clinical needs encompassing a broad spectrum
of clinical areas with attractive regulatory pathways and market
opportunities. Its three lead products provide groundbreaking
approaches to carpal tunnel syndrome (CarpX™), vascular access
(PortIO™) and pediatric ear infections (DisappEAR™). The company is
also developing innovative products in other areas, such as medical
infusions and tissue ablation, while seeking to further expand its
pipeline through engagements with clinician innovators and leading
academic medical centers. For further information, please visit
www.pavmed.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180404005250/en/
InvestorsLHA Investor RelationsKim
Sutton Golodetz, 212-838-3777kgolodetz@lhai.comorMediaPAVmed Inc.212-949-4319info@pavmed.com
PAVmed (NASDAQ:PAVMW)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
PAVmed (NASDAQ:PAVMW)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre PAVmed Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Pavmed Inc. - Warrant